New Delhi, June 29 -- The government on Monday launched Drug Registry, a centralized digital database of medicines to standardize drug information and reduce errors arising from inconsistent naming of medicines.

The move is significant for India's nearly $50-billion pharmaceutical market, where the same medicine is often recorded under different names or formats, creating inconsistencies in clinical decision-making.

The platform allows users to search and identify medications by their generic name, brand name, substance, or manufacturer. Built on standardized terminology and aligned with global standards, the Drug Registry ensures accuracy, transparency, and seamless data exchange across healthcare systems.

"Medicines are one of the mo...